Spatial Uncertainty Data, Modeling, and Communication (R03) | Apply Online

FAQs: Spatial Uncertainty Data, Modeling, and Communication (R03) - PA 11-240

What is the "Spatial Uncertainty Data, Modeling, and Communication (R03)" opportunity (PA 11-240)?

PA 11-240 is a National Institutes of Health (NIH) discretionary grant opportunity that uses the R03 award mechanism to support small, innovative research projects focused on spatial uncertainty in public health data. The emphasis is on understanding where spatial uncertainty comes from, building methods that account for it in analysis, and improving how its impact is communicated to decision-makers and users of public health evidence.

What does "spatial uncertainty" mean in this funding opportunity?

In this context, spatial uncertainty refers to situations where geographic information linked to health data is inaccurate, imprecise, unstable, or otherwise unreliable. This can include issues like geocoding errors, inconsistent address quality, shifting administrative boundaries, positional inaccuracies in environmental exposure surfaces, or location misclassification caused by data aggregation.

Why is spatial uncertainty considered important for public health research?

The opportunity frames spatial uncertainty as a widely important problem because location is often central to public health inference (for example, identifying clusters, estimating exposure-response relationships, or mapping disease risk). If location information is wrong or imprecise and that uncertainty is ignored, study conclusions and maps can look more certain than the underlying data justify.

What is the main goal of the FOA?

The FOA aims to strengthen and make more transparent spatial inference in spatial epidemiology and related public health research areas by (1) diagnosing sources and structure of spatial uncertainty, (2) incorporating that uncertainty into statistical modeling so estimates and conclusions reflect what is known versus assumed, and (3) improving visualization and communication so the impact of spatial uncertainty is understandable and interpretable.

What types of research are encouraged under this FOA?

The FOA encourages methodological innovation that treats location-related error as a first-class statistical issue rather than a minor nuisance. Projects are expected to examine how spatial uncertainty enters real-world public health datasets and then incorporate that uncertainty directly into statistical modeling approaches and communication/visualization tools.

What are examples of spatial uncertainty issues mentioned in the FOA?

Examples specifically noted include geocoding errors, inconsistent address quality, shifting administrative boundaries, positional inaccuracies in environmental exposure surfaces, and location misclassification resulting from data aggregation.

How does the FOA expect researchers to handle spatial uncertainty in analysis?

The FOA emphasizes building statistical modeling approaches that propagate spatial uncertainty into estimation and inference. That means conclusions, risk estimates, cluster detection results, exposure-response relationships, and maps should reflect uncertainty rather than relying on a single assumed location or boundary as if it were exact.

What kinds of outputs or products does the FOA highlight for communicating uncertainty?

It highlights visualization and communication tools that make spatial uncertainty understandable, including new mapping strategies, interactive visual displays, uncertainty surfaces, sensitivity analysis dashboards, or other methods that show how results change when location information is perturbed or when alternative geographic assumptions are used.

What does it mean to treat location-related error as a "first-class statistical issue"?

Within the FOA's framing, it means spatial error should be modeled and accounted for explicitly, not treated as a minor data-cleaning footnote. The goal is that uncertainty in geography meaningfully influences the reported results and their interpretation.

What award mechanism is used for this opportunity?

The award mechanism is the NIH R03. The R03 is typically used for short-duration, limited-scope projects such as pilot studies, feasibility work, early-stage method development, secondary data analyses, or tool creation that could later scale into larger research programs.

What public health domains or program areas are associated with this FOA?

The activity areas span multiple public health domains, reflected in the listed CFDA programs: Environmental Health (93.113), Alcohol Research (93.273), Drug Abuse and Addiction Research (93.279), Cancer Cause and Prevention (93.393), Cancer Control (93.399), Allergy and Infectious Diseases (93.855), Microbiology and Infectious Diseases (93.856), and Child Health and Human Development (93.865).

Does the FOA focus on a single disease area?

No. The FOA presents spatial uncertainty as a cross-cutting methodological concern relevant across many disease areas and exposure settings, including environmental hazards, infectious disease spread, cancer surveillance, and substance use research.

Who is eligible to apply?

Eligibility is broad. Eligible applicants include state, county, and city or township governments; special district governments; public housing authorities and Indian housing authorities; independent school districts; public and private institutions of higher education; nonprofit organizations with or without 501(c)(3) status (excluding universities where noted); for-profit organizations other than small businesses; and small businesses.

Are specific institution types explicitly encouraged or included?

Yes. The FOA explicitly includes Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribal Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based and community-based organizations, regional organizations, eligible federal agencies, U.S. territories or possessions, and non-U.S. entities (foreign organizations).

Are foreign organizations eligible to apply?

Yes. The FOA includes non-U.S. entities (foreign organizations) as eligible applicants.

Are foreign components of U.S. organizations allowed?

Yes. The FOA allows foreign components of U.S. organizations.

Does the opportunity require cost sharing or matching funds?

No. The opportunity does not require cost sharing or matching funds.

When was this funding opportunity posted?

The announcement was posted and created on June 17, 2011.

What was the closing date for applications?

The original and final closing date listed is September 7, 2014.

Is this FOA still active?

No. The FOA is no longer active. It has an archive date of October 8, 2014, and the final closing date was September 7, 2014.

Where can someone find the archived FOA details?

NIH provides an additional information link to the archived program announcement page at http://grants.nih.gov/grants/guide/pa-files/PA-11-240.html.

What should someone do if they cannot access the announcement page?

The FOA directs applicants who have trouble accessing the announcement to contact the NIH Office of Extramural Research (OER) webmaster via the provided email addresses in the announcement.

What kinds of real-world public health data problems does this FOA want projects to address?

Projects are expected to examine how spatial uncertainty enters real-world datasets, such as through address and geocoding quality issues, changes in administrative boundaries, inaccuracies in exposure surfaces, or misclassification introduced by aggregation, and then develop practical ways to account for those issues in analysis and communication.

What is the intended impact of projects funded under this FOA?

The intended impact is stronger, more transparent inference in spatial epidemiology and related fields, along with improved communication of confidence and limitations so that users of public health evidence can better understand what the data support and where uncertainty may affect decisions.